Haemonetics reports Q1 FY2026 results; press release details not provided in filing text

HAEMONETICS CORP

2026-Q1 EPS reported $0.70 revenue$321,394,000

Haemonetics issued press release on Aug 7, 2025 for Q1 ended June 28, 2025.
The filing does not include the press release content; specific numbers not available.
Investors should reference the full press release for earnings details.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.